Cefmenoxime
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Routes of administration | Intramuscular, intravenous |
ATC code | J01DD05 (WHO) |
Pharmacokinetic data | |
Bioavailability | 100% (given IM) |
Protein binding | 50% to 70% |
Metabolism | Negligible |
Biological half-life | 1 hour |
Excretion | Renal, unchanged |
Identifiers | |
| |
CAS Number | 65085-01-0 |
PubChem (CID) | 9570757 |
DrugBank | DB00267 |
ChemSpider | 7845223 |
UNII | KBZ4844CXN |
KEGG | D07641 |
ChEBI | CHEBI:55490 |
ChEMBL | CHEMBL1201224 |
Chemical and physical data | |
Formula | C16H17N9O5S3 |
Molar mass | 511.562 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(what is this?) (verify) |
Cefmenoxime is a third-generation cephalosporin antibiotic.
External links
- Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Deguchi K, Oda S, Tanaka S, Nakane Y, Fukumoto T (1995). "Antibacterial activities of cefmenoxime against recent fresh clinical isolates from patients in sinusitis". Jpn J Antibiot. 48 (5): 602–9. PMID 7637194.
- Paladino J, Fell R (1994). "Pharmacoeconomic analysis of cefmenoxime dual individualization in the treatment of nosocomial pneumonia.". Ann Pharmacother. 28 (3): 384–9. doi:10.1177/106002809402800316. PMID 8193431.
- Duncker G, Reich U, Krausse R (1994). "Cefmenoxime in corneal organ culture.". Ophthalmologica. 208 (5): 262–6. doi:10.1159/000310505. PMID 7816419.
This article is issued from Wikipedia - version of the 5/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.